Allan Lee Shaw founded Shaw Strategic Capital LLC. Currently, Mr. Shaw is Chief Financial Officer of Portage Biotech, Inc.
He is also on the board of Edith & Carl Marks Jch of Bensonhurst and Member of The American Institute of Certified Public Accountants, Member of New York State Society of Certified Public Accountants and Member of Corporate Directors Group.
In his past career Mr. Shaw occupied the position of Chief Financial Officer & Executive Director at NewLead Holdings Ltd., Chief Financial Officer, Secretary & Treasurer at Syndax Pharmaceuticals, Inc., Senior Managing Director at Shaw Strategic Capital LLC, Chief Financial Officer at Serono SA, Chief Financial Officer for Merck Serono SA, Managing Director at Alvarez & Marsal LLC and Manager of Deloitte & Touche LLP.
Mr. Shaw received an undergraduate degree from State University of New York College at Oswego.